Employment of enhanced permeability and retention effect (EPR): Nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer

D Kalyane, N Raval, R Maheshwari, V Tambe… - Materials Science and …, 2019 - Elsevier
In tumorous tissues, the absence of vasculature supportive tissues intimates the formation of
leaky vessels and pores (100 nm to 2 μm in diameter) and the poor lymphatic system offers …

Nanomedicine-based delivery strategies for breast cancer treatment and management

P Tagde, A Najda, K Nagpal, GT Kulkarni… - International journal of …, 2022 - mdpi.com
Breast cancer is one of the most common types of cancer among women globally. It is
caused by mutations in the estrogen/progesterone receptors and conventional treatment …

Overcoming the limits of hypoxia in photodynamic therapy: a carbonic anhydrase IX-targeted approach

HS Jung, J Han, H Shi, S Koo, H Singh… - Journal of the …, 2017 - ACS Publications
A major challenge in photodynamic cancer therapy (PDT) is avoiding PDT-induced hypoxia,
which can lead to cancer recurrence and progression through activation of various …

Canine mammary tumors as a model for human disease

SM Abdelmegeed, S Mohammed - Oncology letters, 2018 - spandidos-publications.com
Animal models for examining human breast cancer (HBC) carcinogenesis have been
extensively studied and proposed. With the recent advent of immunotherapy, significant …

Targeting endothelial permeability in the EPR effect

B Lahooti, RG Akwii, FT Zahra, MS Sajib… - Journal of Controlled …, 2023 - Elsevier
The characteristics of the primary tumor blood vessels and the tumor microenvironment drive
the enhanced permeability and retention (EPR) effect, which confers an advantage towards …

Tumor microenvironment heterogeneity: challenges and opportunities

F Runa, S Hamalian, K Meade, P Shisgal… - Current molecular …, 2017 - Springer
The tumor microenvironment (TME) has been recognized as an integral component of
malignancies in breast and prostate tissues, contributing in confounding ways to tumor …

Challenges and opportunities in metastatic breast cancer treatments: Nano-drug combinations delivered preferentially to metastatic cells may enhance therapeutic …

J Yu, Q Mu, M Fung, X Xu, L Zhu, RJY Ho - Pharmacology & therapeutics, 2022 - Elsevier
Despite advances in breast cancer treatments and related 5-year survival outcomes,
metastatic breast cancer cures remain elusive. The current standard of care includes a …

[HTML][HTML] Current approaches for avoiding the limitations of circulating tumor cells detection methods—implications for diagnosis and treatment of patients with solid …

A Kowalik, M Kowalewska, S Góźdź - Translational Research, 2017 - Elsevier
Eight million people die of cancer each year and 90% of deaths are caused by systemic
disease. Circulating tumor cells (CTCs) contribute to the formation of metastases and thus …

[HTML][HTML] Artificial intelligence–aided diagnosis of breast cancer lymph node metastasis on histologic slides in a digital workflow

B Challa, M Tahir, Y Hu, D Kellough, G Lujan, S Sun… - Modern Pathology, 2023 - Elsevier
Identifying lymph node (LN) metastasis in invasive breast carcinoma can be tedious and
time-consuming. We investigated an artificial intelligence (AI) algorithm to detect LN …

Brain metastasization of breast cancer

T Custodio-Santos, M Videira, MA Brito - Biochimica et Biophysica Acta …, 2017 - Elsevier
Central nervous system metastases have been reported in 15–25% of breast cancer
patients, and the incidence is increasing. Moreover, the survival of these patients is …